Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-21-031655

CEO and CFO bought 1,840 shares at $27.17 ($49,992)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Patel Snehal CEO and CFO 2021-12-14 Purchase +1,840 $27.17 $49,992 1,191,379 D
Open-market purchases · 1,840 sh · avg $27.17 · $49,992
Loading xslF345X03/ownership.xml…